IBDEI0NK ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10608,1,4,0)
;;=4^R41.0
;;^UTILITY(U,$J,358.3,10608,2)
;;=^5019436
;;^UTILITY(U,$J,358.3,10609,0)
;;=G31.09^^42^472^20
;;^UTILITY(U,$J,358.3,10609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10609,1,3,0)
;;=3^Frontotemporal Disease
;;^UTILITY(U,$J,358.3,10609,1,4,0)
;;=4^G31.09
;;^UTILITY(U,$J,358.3,10609,2)
;;=^329916
;;^UTILITY(U,$J,358.3,10610,0)
;;=F02.81^^42^472^37
;;^UTILITY(U,$J,358.3,10610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10610,1,3,0)
;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10610,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10610,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10611,0)
;;=F02.80^^42^472^38
;;^UTILITY(U,$J,358.3,10611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10611,1,3,0)
;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10611,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10611,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10612,0)
;;=F02.81^^42^472^43
;;^UTILITY(U,$J,358.3,10612,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10612,1,3,0)
;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10612,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10612,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10613,0)
;;=F02.80^^42^472^44
;;^UTILITY(U,$J,358.3,10613,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10613,1,3,0)
;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10613,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10613,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10614,0)
;;=G31.84^^42^472^59
;;^UTILITY(U,$J,358.3,10614,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10614,1,3,0)
;;=3^Mild Neurocog D/O d/t FRONTOTEMP LOBAR DEGEN
;;^UTILITY(U,$J,358.3,10614,1,4,0)
;;=4^G31.84
;;^UTILITY(U,$J,358.3,10614,2)
;;=^5003813
;;^UTILITY(U,$J,358.3,10615,0)
;;=F02.81^^42^472^27
;;^UTILITY(U,$J,358.3,10615,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10615,1,3,0)
;;=3^Major Neurocog D/O d/t HIV INFECTION w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10615,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10615,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10616,0)
;;=F02.80^^42^472^28
;;^UTILITY(U,$J,358.3,10616,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10616,1,3,0)
;;=3^Major Neurocog D/O d/t HIV INFECTION w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10616,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10616,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10617,0)
;;=G31.84^^42^472^60
;;^UTILITY(U,$J,358.3,10617,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10617,1,3,0)
;;=3^Mild Neurocog D/O d/t HIV INFECTION
;;^UTILITY(U,$J,358.3,10617,1,4,0)
;;=4^G31.84
;;^UTILITY(U,$J,358.3,10617,2)
;;=^5003813
;;^UTILITY(U,$J,358.3,10618,0)
;;=F02.81^^42^472^29
;;^UTILITY(U,$J,358.3,10618,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10618,1,3,0)
;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10618,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10618,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10619,0)
;;=F02.80^^42^472^30
;;^UTILITY(U,$J,358.3,10619,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10619,1,3,0)
;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10619,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10619,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10620,0)
;;=G31.84^^42^472^61
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0NK 3790 printed Sep 23, 2025@19:28:09 Page 2
IBDEI0NK ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10608,1,4,0)
+2 ;;=4^R41.0
+3 ;;^UTILITY(U,$J,358.3,10608,2)
+4 ;;=^5019436
+5 ;;^UTILITY(U,$J,358.3,10609,0)
+6 ;;=G31.09^^42^472^20
+7 ;;^UTILITY(U,$J,358.3,10609,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,10609,1,3,0)
+10 ;;=3^Frontotemporal Disease
+11 ;;^UTILITY(U,$J,358.3,10609,1,4,0)
+12 ;;=4^G31.09
+13 ;;^UTILITY(U,$J,358.3,10609,2)
+14 ;;=^329916
+15 ;;^UTILITY(U,$J,358.3,10610,0)
+16 ;;=F02.81^^42^472^37
+17 ;;^UTILITY(U,$J,358.3,10610,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,10610,1,3,0)
+20 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
+21 ;;^UTILITY(U,$J,358.3,10610,1,4,0)
+22 ;;=4^F02.81
+23 ;;^UTILITY(U,$J,358.3,10610,2)
+24 ;;=^5003049
+25 ;;^UTILITY(U,$J,358.3,10611,0)
+26 ;;=F02.80^^42^472^38
+27 ;;^UTILITY(U,$J,358.3,10611,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,10611,1,3,0)
+30 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
+31 ;;^UTILITY(U,$J,358.3,10611,1,4,0)
+32 ;;=4^F02.80
+33 ;;^UTILITY(U,$J,358.3,10611,2)
+34 ;;=^5003048
+35 ;;^UTILITY(U,$J,358.3,10612,0)
+36 ;;=F02.81^^42^472^43
+37 ;;^UTILITY(U,$J,358.3,10612,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,10612,1,3,0)
+40 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
+41 ;;^UTILITY(U,$J,358.3,10612,1,4,0)
+42 ;;=4^F02.81
+43 ;;^UTILITY(U,$J,358.3,10612,2)
+44 ;;=^5003049
+45 ;;^UTILITY(U,$J,358.3,10613,0)
+46 ;;=F02.80^^42^472^44
+47 ;;^UTILITY(U,$J,358.3,10613,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,10613,1,3,0)
+50 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
+51 ;;^UTILITY(U,$J,358.3,10613,1,4,0)
+52 ;;=4^F02.80
+53 ;;^UTILITY(U,$J,358.3,10613,2)
+54 ;;=^5003048
+55 ;;^UTILITY(U,$J,358.3,10614,0)
+56 ;;=G31.84^^42^472^59
+57 ;;^UTILITY(U,$J,358.3,10614,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,10614,1,3,0)
+60 ;;=3^Mild Neurocog D/O d/t FRONTOTEMP LOBAR DEGEN
+61 ;;^UTILITY(U,$J,358.3,10614,1,4,0)
+62 ;;=4^G31.84
+63 ;;^UTILITY(U,$J,358.3,10614,2)
+64 ;;=^5003813
+65 ;;^UTILITY(U,$J,358.3,10615,0)
+66 ;;=F02.81^^42^472^27
+67 ;;^UTILITY(U,$J,358.3,10615,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,10615,1,3,0)
+70 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/ Behav Disturb
+71 ;;^UTILITY(U,$J,358.3,10615,1,4,0)
+72 ;;=4^F02.81
+73 ;;^UTILITY(U,$J,358.3,10615,2)
+74 ;;=^5003049
+75 ;;^UTILITY(U,$J,358.3,10616,0)
+76 ;;=F02.80^^42^472^28
+77 ;;^UTILITY(U,$J,358.3,10616,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,10616,1,3,0)
+80 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/o Behav Disturb
+81 ;;^UTILITY(U,$J,358.3,10616,1,4,0)
+82 ;;=4^F02.80
+83 ;;^UTILITY(U,$J,358.3,10616,2)
+84 ;;=^5003048
+85 ;;^UTILITY(U,$J,358.3,10617,0)
+86 ;;=G31.84^^42^472^60
+87 ;;^UTILITY(U,$J,358.3,10617,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,10617,1,3,0)
+90 ;;=3^Mild Neurocog D/O d/t HIV INFECTION
+91 ;;^UTILITY(U,$J,358.3,10617,1,4,0)
+92 ;;=4^G31.84
+93 ;;^UTILITY(U,$J,358.3,10617,2)
+94 ;;=^5003813
+95 ;;^UTILITY(U,$J,358.3,10618,0)
+96 ;;=F02.81^^42^472^29
+97 ;;^UTILITY(U,$J,358.3,10618,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,10618,1,3,0)
+100 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/ Behav Disturb
+101 ;;^UTILITY(U,$J,358.3,10618,1,4,0)
+102 ;;=4^F02.81
+103 ;;^UTILITY(U,$J,358.3,10618,2)
+104 ;;=^5003049
+105 ;;^UTILITY(U,$J,358.3,10619,0)
+106 ;;=F02.80^^42^472^30
+107 ;;^UTILITY(U,$J,358.3,10619,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,10619,1,3,0)
+110 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/o Behav Disturb
+111 ;;^UTILITY(U,$J,358.3,10619,1,4,0)
+112 ;;=4^F02.80
+113 ;;^UTILITY(U,$J,358.3,10619,2)
+114 ;;=^5003048
+115 ;;^UTILITY(U,$J,358.3,10620,0)
+116 ;;=G31.84^^42^472^61
